Colistin- and Carbapenem-Resistant <named-content content-type="genus-species">Escherichia coli</named-content> Harboring <italic toggle="yes">mcr-1</italic> and <italic toggle="yes">bla</italic><sub>NDM-5</sub>, Causing a Complicated Urinary Tract Infection in a Patient from the United States

ABSTRACT Colistin is increasingly used as an antibiotic of last resort for the treatment of carbapenem-resistant Gram-negative infections. The plasmid-borne colistin resistance gene mcr-1 was initially identified in animal and clinical samples from China and subsequently reported worldwide, includin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: José R. Mediavilla, Amee Patrawalla, Liang Chen, Kalyan D. Chavda, Barun Mathema, Christopher Vinnard, Lisa L. Dever, Barry N. Kreiswirth
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2016
Materias:
Acceso en línea:https://doaj.org/article/5dcbc19f225f464ebcdf1e8c43db2b9a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5dcbc19f225f464ebcdf1e8c43db2b9a
record_format dspace
spelling oai:doaj.org-article:5dcbc19f225f464ebcdf1e8c43db2b9a2021-11-15T15:50:19ZColistin- and Carbapenem-Resistant <named-content content-type="genus-species">Escherichia coli</named-content> Harboring <italic toggle="yes">mcr-1</italic> and <italic toggle="yes">bla</italic><sub>NDM-5</sub>, Causing a Complicated Urinary Tract Infection in a Patient from the United States10.1128/mBio.01191-162150-7511https://doaj.org/article/5dcbc19f225f464ebcdf1e8c43db2b9a2016-09-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.01191-16https://doaj.org/toc/2150-7511ABSTRACT Colistin is increasingly used as an antibiotic of last resort for the treatment of carbapenem-resistant Gram-negative infections. The plasmid-borne colistin resistance gene mcr-1 was initially identified in animal and clinical samples from China and subsequently reported worldwide, including in the United States. Of particular concern is the spread of mcr-1 into carbapenem-resistant bacteria, thereby creating strains that approach pan-resistance. While several reports of mcr-1 have involved carbapenem-resistant strains, no such isolates have been described in the United States. Here, we report the isolation and identification of an Escherichia coli strain harboring both mcr-1 and carbapenemase gene blaNDM-5 from a urine sample in a patient without recent travel outside the United States. The isolate exhibited resistance to both colistin and carbapenems, but was susceptible to amikacin, aztreonam, gentamicin, nitrofurantoin, tigecycline, and trimethoprim-sulfamethoxazole. The mcr-1- and blaNDM-5-harboring plasmids were completely sequenced and shown to be highly similar to plasmids previously reported from China. The strain in this report was first isolated in August 2014, highlighting an earlier presence of mcr-1 within the United States than previously recognized. IMPORTANCE Colistin has become the last line of defense for the treatment of infections caused by Gram-negative bacteria resistant to multiple classes of antibiotics, in particular carbapenem-resistant Enterobacteriaceae (CRE). Resistance to colistin, encoded by the plasmid-borne gene mcr-1, was first identified in animal and clinical samples from China in November 2015 and has subsequently been reported from numerous other countries. In April 2016, mcr-1 was identified in a carbapenem-susceptible Escherichia coli strain from a clinical sample in the United States, followed by a second report from a carbapenem-susceptible E. coli strain originally isolated in May 2015. We report the isolation and identification of an E. coli strain harboring both colistin (mcr-1) and carbapenem (blaNDM-5) resistance genes, originally isolated in August 2014 from urine of a patient with recurrent urinary tract infections. To our knowledge, this is the first report in the United States of a clinical bacterial isolate with both colistin and carbapenem resistance, highlighting the importance of active surveillance efforts for colistin- and carbapenem-resistant organisms.José R. MediavillaAmee PatrawallaLiang ChenKalyan D. ChavdaBarun MathemaChristopher VinnardLisa L. DeverBarry N. KreiswirthAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 7, Iss 4 (2016)
institution DOAJ
collection DOAJ
language EN
topic Microbiology
QR1-502
spellingShingle Microbiology
QR1-502
José R. Mediavilla
Amee Patrawalla
Liang Chen
Kalyan D. Chavda
Barun Mathema
Christopher Vinnard
Lisa L. Dever
Barry N. Kreiswirth
Colistin- and Carbapenem-Resistant <named-content content-type="genus-species">Escherichia coli</named-content> Harboring <italic toggle="yes">mcr-1</italic> and <italic toggle="yes">bla</italic><sub>NDM-5</sub>, Causing a Complicated Urinary Tract Infection in a Patient from the United States
description ABSTRACT Colistin is increasingly used as an antibiotic of last resort for the treatment of carbapenem-resistant Gram-negative infections. The plasmid-borne colistin resistance gene mcr-1 was initially identified in animal and clinical samples from China and subsequently reported worldwide, including in the United States. Of particular concern is the spread of mcr-1 into carbapenem-resistant bacteria, thereby creating strains that approach pan-resistance. While several reports of mcr-1 have involved carbapenem-resistant strains, no such isolates have been described in the United States. Here, we report the isolation and identification of an Escherichia coli strain harboring both mcr-1 and carbapenemase gene blaNDM-5 from a urine sample in a patient without recent travel outside the United States. The isolate exhibited resistance to both colistin and carbapenems, but was susceptible to amikacin, aztreonam, gentamicin, nitrofurantoin, tigecycline, and trimethoprim-sulfamethoxazole. The mcr-1- and blaNDM-5-harboring plasmids were completely sequenced and shown to be highly similar to plasmids previously reported from China. The strain in this report was first isolated in August 2014, highlighting an earlier presence of mcr-1 within the United States than previously recognized. IMPORTANCE Colistin has become the last line of defense for the treatment of infections caused by Gram-negative bacteria resistant to multiple classes of antibiotics, in particular carbapenem-resistant Enterobacteriaceae (CRE). Resistance to colistin, encoded by the plasmid-borne gene mcr-1, was first identified in animal and clinical samples from China in November 2015 and has subsequently been reported from numerous other countries. In April 2016, mcr-1 was identified in a carbapenem-susceptible Escherichia coli strain from a clinical sample in the United States, followed by a second report from a carbapenem-susceptible E. coli strain originally isolated in May 2015. We report the isolation and identification of an E. coli strain harboring both colistin (mcr-1) and carbapenem (blaNDM-5) resistance genes, originally isolated in August 2014 from urine of a patient with recurrent urinary tract infections. To our knowledge, this is the first report in the United States of a clinical bacterial isolate with both colistin and carbapenem resistance, highlighting the importance of active surveillance efforts for colistin- and carbapenem-resistant organisms.
format article
author José R. Mediavilla
Amee Patrawalla
Liang Chen
Kalyan D. Chavda
Barun Mathema
Christopher Vinnard
Lisa L. Dever
Barry N. Kreiswirth
author_facet José R. Mediavilla
Amee Patrawalla
Liang Chen
Kalyan D. Chavda
Barun Mathema
Christopher Vinnard
Lisa L. Dever
Barry N. Kreiswirth
author_sort José R. Mediavilla
title Colistin- and Carbapenem-Resistant <named-content content-type="genus-species">Escherichia coli</named-content> Harboring <italic toggle="yes">mcr-1</italic> and <italic toggle="yes">bla</italic><sub>NDM-5</sub>, Causing a Complicated Urinary Tract Infection in a Patient from the United States
title_short Colistin- and Carbapenem-Resistant <named-content content-type="genus-species">Escherichia coli</named-content> Harboring <italic toggle="yes">mcr-1</italic> and <italic toggle="yes">bla</italic><sub>NDM-5</sub>, Causing a Complicated Urinary Tract Infection in a Patient from the United States
title_full Colistin- and Carbapenem-Resistant <named-content content-type="genus-species">Escherichia coli</named-content> Harboring <italic toggle="yes">mcr-1</italic> and <italic toggle="yes">bla</italic><sub>NDM-5</sub>, Causing a Complicated Urinary Tract Infection in a Patient from the United States
title_fullStr Colistin- and Carbapenem-Resistant <named-content content-type="genus-species">Escherichia coli</named-content> Harboring <italic toggle="yes">mcr-1</italic> and <italic toggle="yes">bla</italic><sub>NDM-5</sub>, Causing a Complicated Urinary Tract Infection in a Patient from the United States
title_full_unstemmed Colistin- and Carbapenem-Resistant <named-content content-type="genus-species">Escherichia coli</named-content> Harboring <italic toggle="yes">mcr-1</italic> and <italic toggle="yes">bla</italic><sub>NDM-5</sub>, Causing a Complicated Urinary Tract Infection in a Patient from the United States
title_sort colistin- and carbapenem-resistant <named-content content-type="genus-species">escherichia coli</named-content> harboring <italic toggle="yes">mcr-1</italic> and <italic toggle="yes">bla</italic><sub>ndm-5</sub>, causing a complicated urinary tract infection in a patient from the united states
publisher American Society for Microbiology
publishDate 2016
url https://doaj.org/article/5dcbc19f225f464ebcdf1e8c43db2b9a
work_keys_str_mv AT josermediavilla colistinandcarbapenemresistantnamedcontentcontenttypegenusspeciesescherichiacolinamedcontentharboringitalictoggleyesmcr1italicanditalictoggleyesblaitalicsubndm5subcausingacomplicatedurinarytractinfectioninapatientfromtheunitedstates
AT ameepatrawalla colistinandcarbapenemresistantnamedcontentcontenttypegenusspeciesescherichiacolinamedcontentharboringitalictoggleyesmcr1italicanditalictoggleyesblaitalicsubndm5subcausingacomplicatedurinarytractinfectioninapatientfromtheunitedstates
AT liangchen colistinandcarbapenemresistantnamedcontentcontenttypegenusspeciesescherichiacolinamedcontentharboringitalictoggleyesmcr1italicanditalictoggleyesblaitalicsubndm5subcausingacomplicatedurinarytractinfectioninapatientfromtheunitedstates
AT kalyandchavda colistinandcarbapenemresistantnamedcontentcontenttypegenusspeciesescherichiacolinamedcontentharboringitalictoggleyesmcr1italicanditalictoggleyesblaitalicsubndm5subcausingacomplicatedurinarytractinfectioninapatientfromtheunitedstates
AT barunmathema colistinandcarbapenemresistantnamedcontentcontenttypegenusspeciesescherichiacolinamedcontentharboringitalictoggleyesmcr1italicanditalictoggleyesblaitalicsubndm5subcausingacomplicatedurinarytractinfectioninapatientfromtheunitedstates
AT christophervinnard colistinandcarbapenemresistantnamedcontentcontenttypegenusspeciesescherichiacolinamedcontentharboringitalictoggleyesmcr1italicanditalictoggleyesblaitalicsubndm5subcausingacomplicatedurinarytractinfectioninapatientfromtheunitedstates
AT lisaldever colistinandcarbapenemresistantnamedcontentcontenttypegenusspeciesescherichiacolinamedcontentharboringitalictoggleyesmcr1italicanditalictoggleyesblaitalicsubndm5subcausingacomplicatedurinarytractinfectioninapatientfromtheunitedstates
AT barrynkreiswirth colistinandcarbapenemresistantnamedcontentcontenttypegenusspeciesescherichiacolinamedcontentharboringitalictoggleyesmcr1italicanditalictoggleyesblaitalicsubndm5subcausingacomplicatedurinarytractinfectioninapatientfromtheunitedstates
_version_ 1718427400429109248